Increased serum potassium affects renal outcomes: a post hoc analysis of the reduction of endpoints in NIDOM with the Angiotensin II Antagonist Losartan (Renaal) trial.

Y. Miao; D. Dobre; H.J. Lambers Heerspink; B.M. Brenner; M.E. Cooper; H. H. Parving; S. Shahinfar; D.E. Grobbee; D. de Zeeuw

Increased serum potassium affects renal outcomes: a post hoc analysis of the reduction of endpoints in NIDOM with the Angiotensin II Antagonist Losartan (Renaal) trial.

Y. Miao, D. Dobre, H.J. Lambers Heerspink, B.M. Brenner, M.E. Cooper, H. H. Parving, S. Shahinfar, D.E. Grobbee, D. de Zeeuw

Research output: Contribution to journal › Article › Academic › peer-review

Original language	English
Pages (from-to)	44-50
Number of pages	7
Journal	Diabetologia
Volume	54
Issue number	1
Publication status	Published - 2011

Cite this

@article{57b4e7f642d3484e9a7f3ed4f133c061,

title = "Increased serum potassium affects renal outcomes: a post hoc analysis of the reduction of endpoints in NIDOM with the Angiotensin II Antagonist Losartan (Renaal) trial.",

author = "Y. Miao and D. Dobre and {Lambers Heerspink}, H.J. and B.M. Brenner and M.E. Cooper and Parving, {H. H.} and S. Shahinfar and D.E. Grobbee and {de Zeeuw}, D.",

year = "2011",

language = "English",

volume = "54",

pages = "44--50",

journal = "Diabetologia",

issn = "0012-186X",

publisher = "Springer-Verlag",

number = "1",

}

TY - JOUR

T1 - Increased serum potassium affects renal outcomes: a post hoc analysis of the reduction of endpoints in NIDOM with the Angiotensin II Antagonist Losartan (Renaal) trial.

AU - Miao, Y.

AU - Dobre, D.

AU - Lambers Heerspink, H.J.

AU - Brenner, B.M.

AU - Cooper, M.E.

AU - Parving, H. H.

AU - Shahinfar, S.

AU - Grobbee, D.E.

AU - de Zeeuw, D.

PY - 2011

Y1 - 2011

M3 - Article

SN - 0012-186X

VL - 54

SP - 44

EP - 50

JO - Diabetologia

JF - Diabetologia

IS - 1

ER -